Basic Information
Swift Biosciences Develops and Commercializes NGS Library Preparation Kits to Support Genomics, Translational, and Clinical Research Technologies. Our proprietary technology broadens the range of sample input to expand the applications of next-generation sequencing (NGS). Swift library kits are designed to maximize data output, provide the most comprehensive coverage on the market, and reduce sequencing costs. Our products facilitate library normalization and analyze applications for DNA and RNA samples, including low-input liquid biopsies (circulating, cell-free DNA), methylation sequencing, whole-genome sequencing, exome and transcriptome sequencing, chromatin studies, and samples derived from formalin-fixed paraffin-embedded tissues. Swift’s mission is to provide research tools that contribute to the long-term improvement of health for individuals and their communities worldwide, particularly in the fight against cancer and understanding the complexity of genetic diseases. We strive to develop tools directly applicable to research in agricultural genomics, biotechnology, metagenomics, and the pharmaceutical industry.
Swift Biosciences, Inc.
Michigan,United States of America
15~50 people
January 01, 2010
info@swiftbiosci.com

